English | Español

Boehringer-Ingelheim
Carol Ostrow | Dec 15, 2017

Boehringer Ingelheim collaborations yield vaccine technology, cancer treatments
Ruth de Jauregui | Jun 14, 2017

Boehringer Ingelheim, Eli Lilly to collaborate in trial of empagliflozin for chronic kidney disease
Gene Johnson | Feb 25, 2017

Combination therapy targets lung cancer
Carol Ostrow | Feb 19, 2017

Partnership spurs efforts against COPD
Amanda Rupp | Jun 28, 2016

Boehringer Ingelheim board of managing directors introduces new member
Amanda Rupp | Jun 5, 2016

Boehringer Ingelheim, Inventiva collaborate for idiopathic pulmonary fibrosis treatments
Amanda Rupp | May 31, 2016

Boehringer Ingelheim to increase HIV/AIDS medication access
Amanda Rupp | May 25, 2016

BioMed X, Boehringer Ingelheim partner for psychiatric treatments

Trending
+ Pharmaceuticals
Patient Daily | Jun 2, 2025

PathAI collaborates with Northwestern Medicine on digital pathology advancements
+ Regulatory
Patient Daily | May 30, 2025

Alliance for Pharmacy Compounding calls for eliminating redundant, unauthorized, or ineffective regulation
+ Pharmaceuticals
Patient Daily | Jun 5, 2025

Exon 20 Group questions effectiveness of 340B drug program
+ Pharmaceuticals
Patient Daily | Jun 5, 2025

New study identifies indicators for HER2+ breast cancer therapy response